On Monday, the New Jersey pharma announced its rVSV-ZEBOV has won the FDA’s Breakthrough Therapy Designation and the EMA’s Priority Medicines status.

Pfizer’s blockbuster vaccine Prevenar 13 will soon get a boost in a host of international markets. The shot won WHO backing in a new, easier-to-store…

With HPV rates on the rise in the U.K., researchers are pushing health authorities to include boys in an HPV vaccination program currently offered to females…

Already the world’s best-selling vaccine, Pfizer’s Prevnar 13 got yet another boost Tuesday with an expanded FDA approval in adults aged 18 to 49.

In a unanimous vote, the CDC’s ACIP recommended PaxVax’s oral cholera vaccine for adults traveling to areas where cholera is prevalent.

​Dealing a blow to AstraZeneca in its largest FluMist Quadrivalent market, a CDC committee has stiff-armed the nasal vaccine for the upcoming season. Why? The…

Groups encouraging HPV vaccination will have more firepower for their arguments as a new analysis--citing a decade’s worth of real-world data for Merck’s…

The worldwide Zika vaccine race has reached a new milestone as Plymouth Meeting, PA’s Inovio Pharmaceuticals says it has received the first approval to begin…

While many in the world are focusing on the headline-grabbing Zika outbreak, another mosquito-borne disease has left hundreds dead in Angola. Responding to the…

Regulatory